{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:11:12Z","timestamp":1775693472412,"version":"3.50.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["16K11432"],"award-info":[{"award-number":["16K11432"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["23591094, 26461137, 17K09587"],"award-info":[{"award-number":["23591094, 26461137, 17K09587"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["15K20355 and 17K17074"],"award-info":[{"award-number":["15K20355 and 17K17074"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Ischemic preconditioning (IPC) is the most powerful endogenous cardioprotective form of cellular adaptation. However, the inhibitory or augmenting mechanism underlying cardioprotection via IPC remains largely unknown. Suppressor of cytokine signaling-3 (SOCS3) is a cytokine-inducible potent negative feedback regulator of the signal transducer and activator of transcription-3 (STAT3) signaling pathway. Here, we aimed to determine whether cardiac SOCS3 deficiency and IPC would synergistically reduce infarct size after myocardial ischemia reperfusion injury. We evaluated STAT3 activation and SOCS3 induction after ischemic conditioning (IC) using western blot analysis and real-time PCR, and found that myocardial IC alone transiently activated myocardial STAT3 and correspondingly induced SOCS3 expression in wild-type mice. Compared with wild-type mice, cardiac-specific SOCS3 knockout (SOCS3-CKO) mice showed significantly greater and more sustained IC-induced STAT3 activation. Following ischemia reperfusion, IPC substantially reduced myocardial infarct size and significantly enhanced STAT3 phosphorylation in SOCS3-CKO mice compared to in wild-type mice. Real-time PCR array analysis revealed that SOCS3-CKO mice after IC exhibited significantly increased expressions of several anti-apoptotic genes and SAFE pathway-related genes. Moreover, real-time PCR analysis revealed that myocardial IC alone rapidly induced expression of the STAT3-activating cytokine erythropoietin in the kidney at 1 h post-IC. We also found that the circulating erythropoietin level was promptly increased at 1 h after myocardial IC. Myocardial SOCS3 deficiency and IPC exert synergistic effects in the prevention of myocardial injury after ischemia reperfusion. Our present results suggest that myocardial SOCS3 is a potent inhibitor of IPC-induced cardioprotection, and that myocardial SOCS3 inhibition augment IPC-mediated cardioprotection during ischemia reperfusion injury.<\/jats:p>","DOI":"10.1371\/journal.pone.0254712","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T17:28:03Z","timestamp":1626974883000},"page":"e0254712","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["SOCS3 deficiency in cardiomyocytes elevates sensitivity of ischemic preconditioning that synergistically ameliorates myocardial ischemia reperfusion injury"],"prefix":"10.1371","volume":"16","author":[{"given":"Shoichiro","family":"Nohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0422-1145","authenticated-orcid":true,"given":"Hideo","family":"Yasukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koutatsu","family":"Shimozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Akagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8947-109X","authenticated-orcid":true,"given":"Yoshihiro","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"issue":"13","key":"pone.0254712.ref001","first-page":"935","article-title":"Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations","volume":"38","author":"DJ Hausenloy","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"pone.0254712.ref002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","article-title":"Ischaemic conditioning and reperfusion injury","volume":"13","author":"DJ Hausenloy","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"pone.0254712.ref003","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"G Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"pone.0254712.ref004","first-page":"774","article-title":"The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge","volume":"38","author":"G Heusch","year":"2017","journal-title":"Eur Heart J"},{"issue":"11","key":"pone.0254712.ref005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrcardio.2017.102","article-title":"New and revisited approaches to preserving the reperfused myocardium","volume":"14","author":"RA Kloner","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"pone.0254712.ref006","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/cvr\/cvu225","article-title":"ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies","volume":"104","author":"S Lecour","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"5","key":"pone.0254712.ref007","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium","volume":"74","author":"CE Murry","year":"1986","journal-title":"Circulation"},{"issue":"11","key":"pone.0254712.ref008","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrcardio.2011.85","article-title":"The therapeutic potential of ischemic conditioning: an update","volume":"8","author":"DJ Hausenloy","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"pone.0254712.ref009","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCRESAHA.116.308736","article-title":"Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning","volume":"119","author":"G Heusch","year":"2016","journal-title":"Circ Res"},{"issue":"5","key":"pone.0254712.ref010","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1253\/circj.CJ-12-0132","article-title":"Cardioprotection from ischemia\/reperfusion injury: basic and translational research","volume":"76","author":"T Minamino","year":"2012","journal-title":"Circ J"},{"issue":"4","key":"pone.0254712.ref011","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.yjmcc.2011.01.002","article-title":"A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning","volume":"50","author":"R Bolli","year":"2011","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"pone.0254712.ref012","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00395-007-0658-z","article-title":"Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis","volume":"102","author":"P Fischer","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"pone.0254712.ref013","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fcvm.2019.00150","article-title":"An Update on the Multifaceted Roles of STAT3 in the","volume":"6","author":"Z Harhous","year":"2019","journal-title":"Heart. Front Cardiovasc Med"},{"issue":"2","key":"pone.0254712.ref014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.RES.0000134921.50377.61","article-title":"Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury","volume":"95","author":"D Hilfiker-Kleiner","year":"2004","journal-title":"Circ Res"},{"issue":"1","key":"pone.0254712.ref015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00395-017-0660-z","article-title":"STAT3 as a common signal of ischemic conditioning: a lesson on \"rigor and reproducibility\" in preclinical studies on cardioprotection","volume":"113","author":"P Kleinbongard","year":"2018","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"pone.0254712.ref016","doi-asserted-by":"crossref","first-page":"H569","DOI":"10.1152\/ajpheart.00060.2012","article-title":"Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart","volume":"303","author":"M Obana","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"pone.0254712.ref017","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fcvm.2015.00036","article-title":"Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues","volume":"2","author":"FA Zouein","year":"2015","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"pone.0254712.ref018","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yjmcc.2009.03.019","article-title":"Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?","volume":"47","author":"S Lecour","year":"2009","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"pone.0254712.ref019","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCRESAHA.107.164699","article-title":"Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice","volume":"102","author":"K Boengler","year":"2008","journal-title":"Circ Res"},{"issue":"2","key":"pone.0254712.ref020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-018-0670-5","article-title":"The SAFE pathway for cardioprotection: is this a promising target?","volume":"113","author":"N Hadebe","year":"2018","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"pone.0254712.ref021","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning","volume":"116","author":"G Heusch","year":"2015","journal-title":"Circ Res"},{"issue":"4","key":"pone.0254712.ref022","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cardiores.2004.06.019","article-title":"Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning","volume":"63","author":"RM Smith","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"1","key":"pone.0254712.ref023","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/cvr\/cvn067","article-title":"Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning","volume":"79","author":"N Suleman","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"3","key":"pone.0254712.ref024","doi-asserted-by":"crossref","first-page":"H478","DOI":"10.1152\/ajpheart.00749.2016","article-title":"Ischemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3","volume":"312","author":"S Gent","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6636","key":"pone.0254712.ref025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/43219","article-title":"Structure and function of a new STAT-induced STAT inhibitor","volume":"387","author":"T Naka","year":"1997","journal-title":"Nature"},{"issue":"4","key":"pone.0254712.ref026","first-page":"234","article-title":"SOCS3: A novel therapeutic target for cardioprotection","volume":"1","author":"H Yasukawa","year":"2012","journal-title":"Jakstat"},{"key":"pone.0254712.ref027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.immunol.18.1.143","article-title":"Negative regulation of cytokine signaling pathways","volume":"18","author":"H Yasukawa","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"pone.0254712.ref028","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2443.1999.00263.x","article-title":"Cytokine-inducible SH2 protein-3 (CIS3\/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain","volume":"4","author":"A Sasaki","year":"1999","journal-title":"Genes Cells"},{"issue":"5","key":"pone.0254712.ref029","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/emboj\/18.5.1309","article-title":"The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop","volume":"18","author":"H Yasukawa","year":"1999","journal-title":"Embo j"},{"issue":"5","key":"pone.0254712.ref030","doi-asserted-by":"crossref","first-page":"e0127942","DOI":"10.1371\/journal.pone.0127942","article-title":"Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules","volume":"10","author":"T Nagata","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"pone.0254712.ref031","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jacc.2011.10.887","article-title":"Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction","volume":"59","author":"T Oba","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"pone.0254712.ref032","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/CIRCULATIONAHA.106.642454","article-title":"Innate defense mechanism against virus infection within the cardiac myocyte requiring gp130-STAT3 signaling","volume":"114","author":"T Yajima","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"pone.0254712.ref033","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI13939","article-title":"Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways","volume":"108","author":"H Yasukawa","year":"2001","journal-title":"J Clin Invest"},{"issue":"4","key":"pone.0254712.ref034","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1172\/JCI16491","article-title":"The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury","volume":"111","author":"H Yasukawa","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"pone.0254712.ref035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni938","article-title":"IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages","volume":"4","author":"H Yasukawa","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"pone.0254712.ref036","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1172\/JCI119509","article-title":"Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo","volume":"100","author":"R Agah","year":"1997","journal-title":"J Clin Invest"},{"issue":"8","key":"pone.0254712.ref037","doi-asserted-by":"crossref","first-page":"e014814","DOI":"10.1161\/JAHA.119.014814","article-title":"Interleukin-22 Directly Activates Myocardial STAT3 (Signal Transducer and Activator of Transcription-3) Signaling Pathway and Prevents Myocardial Ischemia Reperfusion Injury","volume":"9","author":"J Takahashi","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"pone.0254712.ref038","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1253\/circj.CJ-14-1171","article-title":"Renal Nerve-Mediated Erythropoietin Release Confers Cardioprotection During Remote Ischemic Preconditioning","volume":"79","author":"T Oba","year":"2015","journal-title":"Circ J"},{"issue":"3","key":"pone.0254712.ref039","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/emboj\/cdg057","article-title":"SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation","volume":"22","author":"Y Takahashi","year":"2003","journal-title":"Embo j"},{"issue":"2","key":"pone.0254712.ref040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1050-1738(02)00230-X","article-title":"Role of the JAK-STAT pathway in protection against myocardial ischemia\/reperfusion injury","volume":"13","author":"R Bolli","year":"2003","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"pone.0254712.ref041","doi-asserted-by":"crossref","first-page":"H797","DOI":"10.1152\/ajpheart.01334.2005","article-title":"STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardium","volume":"291","author":"KL Butler","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"pone.0254712.ref042","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1073\/pnas.96.12.6964","article-title":"Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter","volume":"96","author":"CJ Auernhammer","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"pone.0254712.ref043","doi-asserted-by":"crossref","first-page":"29338","DOI":"10.1074\/jbc.M003456200","article-title":"CIS3\/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2","volume":"275","author":"A Sasaki","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"pone.0254712.ref044","first-page":"e25045","article-title":"SOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokines","volume":"2","author":"CA White","year":"2013","journal-title":"Jakstat"},{"issue":"18","key":"pone.0254712.ref045","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.2011.592","article-title":"Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial","volume":"305","author":"SS Najjar","year":"2011","journal-title":"Jama"},{"issue":"5","key":"pone.0254712.ref046","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCINTERVENTIONS.109.904425","article-title":"Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial","volume":"3","author":"I Ott","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"pone.0254712.ref047","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1160\/TH15-07-0589","article-title":"Stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute myocardial infarction. Long-term results of the REVIVAL-2 trial","volume":"115","author":"B Steppich","year":"2016","journal-title":"Thromb Haemost"},{"issue":"1","key":"pone.0254712.ref048","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/eurjhf\/hfr148","article-title":"Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials","volume":"14","author":"H Zimmet","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"pone.0254712.ref049","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/hh0701.088512","article-title":"Induction of JAB\/SOCS-1\/SSI-1 and CIS3\/SOCS-3\/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo","volume":"88","author":"I Hamanaka","year":"2001","journal-title":"Circ Res"},{"issue":"7","key":"pone.0254712.ref050","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm1071","article-title":"Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity","volume":"10","author":"H Mori","year":"2004","journal-title":"Nat Med"},{"issue":"5","key":"pone.0254712.ref051","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood.V92.5.1668","article-title":"A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons","volume":"92","author":"H Sakamoto","year":"1998","journal-title":"Blood"},{"key":"pone.0254712.ref052","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gene.2019.01.044","article-title":"Adeno-associated virus 9-mediated RNA interference targeting SOCS3 alleviates diastolic heart failure in rats","volume":"697","author":"J Gao","year":"2019","journal-title":"Gene"},{"issue":"8","key":"pone.0254712.ref053","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1111\/j.1476-5381.2010.00671.x","article-title":"Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation","volume":"160","author":"M Collino","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"1","key":"pone.0254712.ref054","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","volume":"9","author":"NPD Liau","year":"2018","journal-title":"Nat Commun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T17:28:37Z","timestamp":1626974917000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254712"}},"subtitle":[],"editor":[{"given":"Meijing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0254712","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}